Kherabi Y, de Castro N, Sellier PO, Hamet G, et al. Efficacy and safety of efavirenz, raltegravir and dolutegravir in HIV-1/TB
co-infection. A multicenter retrospective cohort study in France. J Acquir Immune Defic Syndr 2022 May 26. pii: 00126334-990000000-00052.
PMID: 35616997